Enter your information to understand your homocysteine levels.

The History of Homocysteine

Homocysteine was first successfully synthesized in the laboratory in 1932 by American biochemist Vincent du Vigneaud, who derived it directly from the amino acid methionine while investigating the broader chemistry of sulfur-containing compounds within the body. For decades afterward, homocysteine remained a relatively obscure biochemical curiosity, until American pathologist Kilmer McCully proposed in 1969 that dangerously elevated homocysteine levels might directly contribute to atherosclerosis and cardiovascular disease, a hypothesis he developed after personally observing severe, unusually early vascular damage in children born with a rare genetic disorder called homocystinuria. McCully's initially controversial idea faced considerable professional skepticism for years, but subsequent decades of accumulating research gradually validated much of his original thinking, eventually establishing homocysteine as a genuinely recognized, independent cardiovascular risk factor worth measuring routinely in ordinary clinical practice around the world today.

What Homocysteine Actually Is

Homocysteine is an amino acid produced naturally as an intermediate byproduct whenever the body metabolizes methionine, an essential amino acid obtained primarily from ordinary dietary protein sources like meat, eggs, and dairy products consumed regularly throughout daily life. Under normal, healthy circumstances, the body quickly converts homocysteine back into methionine or further breaks it down entirely, a recycling process that depends heavily on adequate levels of vitamin B6, vitamin B12, and folate working properly together. When any of these essential B vitamins become deficient, homocysteine can accumulate to abnormally elevated levels in the bloodstream, potentially damaging blood vessel walls gradually over time and meaningfully increasing the long-term risk of blood clots, stroke, and broader underlying cardiovascular disease overall.

How Homocysteine Is Measured

Homocysteine is most commonly measured today using automated immunoassay methods, in which specific antibodies bind directly to homocysteine molecules present in a blood sample, generating a measurable signal that is directly proportional to its actual concentration in that sample. Some specialized reference laboratories instead rely on high-performance liquid chromatography, a considerably more precise separation technique that can clearly distinguish homocysteine from other structurally similar compounds circulating simultaneously throughout the bloodstream at any given moment. Because B vitamin status so directly influences homocysteine levels, doctors frequently order vitamin B12 and folate testing alongside homocysteine itself, helping doctors correctly identify and directly address any genuine underlying nutritional deficiency that may be driving an elevated result in the first place.

Scientists Behind the Science

Vincent du Vigneaud's original 1932 synthesis gave researchers their very first pure, laboratory-made sample of homocysteine to study directly, laying essential groundwork for all the biochemical research that would eventually follow over the many subsequent decades of dedicated scientific investigation worldwide. Kilmer McCully's bold and, at the time, genuinely unpopular 1969 hypothesis connecting homocysteine to cardiovascular disease initially cost him significant professional standing within the medical research community, yet his persistent, patient advocacy ultimately proved remarkably prescient many decades later. Together, their combined contributions gradually and decisively transformed an obscure sulfur-containing amino acid into a widely recognized, independently significant marker of cardiovascular risk now measured routinely in clinics and hospitals all around the world today.